Suchergebnisse - "Pushpakom, Sudeep"

PubPharm (39)

1

Cardiovascular drugs and COVID-19 clinical outcomes : a systematic review and meta-analysis of randomized controlled trials

enthalten in: British journal of clinical pharmacology | 2022

von Asiimwe, I. | Pushpakom, S. | Turner, R. | +3

2

Cardiovascular drugs and COVID‐19 clinical outcomes : a systematic review and meta‐analysis of randomized controlled trials

enthalten in: British Journal of Clinical Pharmacology | 2022

von Asiimwe, I. | Pushpakom, S. | Turner, R. | +3

3

Cardiovascular drugs and COVID-19 clinical outcomes : A living systematic review and meta-analysis

enthalten in: British journal of clinical pharmacology | 2021

von Asiimwe, I. | Pushpakom, S. | Turner, R. | +3

4

Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis

enthalten in: bioRxiv.org | 2021

von Asiimwe, I. | Pushpakom, S. | Turner, R. | +3

5

Cardiovascular drugs and COVID‐19 clinical outcomes : A living systematic review and meta‐analysis

enthalten in: British Journal of Clinical Pharmacology | 2021

von Asiimwe, I. | Pushpakom, S. | Turner, R. | +3

6

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]) : An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Pushpakom, S. | Kolamunnage-Dona, R. | Taylor, C. | +27

7

Nilotinib-induced metabolic dysfunction : insights from a translational study using in vitro adipocyte models and patient cohorts

enthalten in: Leukemia | 2019

von Sadiq, S. | Owen, E. | Foster, T. | +5

8

Drug repurposing : progress, challenges and recommendations

enthalten in: Nature reviews. Drug discovery | 2019

von Pushpakom, S. | Iorio, F. | Eyers, P. | +11

9

Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro

enthalten in: Diabetes & vascular disease research | 2018

von Pushpakom, S. | Adaikalakoteswari, A. | Owen, A. | +5

10

Telmisartan and Insulin Resistance in HIV (TAILoR) : protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

enthalten in: BMJ open | 2015

von Pushpakom, S. | Taylor, C. | Kolamunnage-Dona, R. | +9